|

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

RECRUITINGN/ASponsored by Fred Hutchinson Cancer Center
Actively Recruiting
PhaseN/A
SponsorFred Hutchinson Cancer Center
Started2026-03-01
Est. completion2029-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial tests an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention to address burnout among gynecologic oncology clinicians. Stress and burnout among gynecologic oncology clinicians can have far-reaching impacts not only on physicians at the individual level (e.g., distress, mental illness) but also at the professional (e.g., worse patient outcomes, increased errors) and societal levels (fewer physicians in this specialty, more system strain). The original Helping Ovarian Cancer Patients Cope (HOPE) is a workshop to promote hope among patients with ovarian cancer through creating positive narratives using the hope theory and social-cognitive theory. The adapted intervention for clinicals (HOPE-C) will use the same concepts but tailored to clinician experiences by fostering peer support and retelling their challenging stories and may address burnout for gynecologic oncology clinicians.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 18 years of age or older
* English speaking
* Able to provide informed consent
* Working with patients with ovarian cancer (gynecologic oncologists, medical oncologists, nurses, social workers, and advance practice providers \[APPs\])

Conditions3

CancerOvarian CarcinomaPsychiatric Disorder

Locations1 site

Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109
Megan J. Shen, PhD206-667-4172mshen2@fredhutch.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.